Gentisin
CAS No. 437-50-3
Gentisin( —— )
Catalog No. M29151 CAS No. 437-50-3
Gentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 883 | Get Quote |
|
| 10MG | 1215 | Get Quote |
|
| 25MG | 1764 | Get Quote |
|
| 50MG | 2412 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NameGentisin
-
NoteResearch use only, not for human use.
-
Brief DescriptionGentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity.
-
DescriptionGentisin is a novel inhibitor of vascular smooth muscle cells (VSMC) proliferation with an IC50 value of 7.84 μM. Gentisin has mutagenic activity.(In Vitro):The anti-proliferative effect of Gentisin was confirmed by the quantification of DNA synthesis (BrdU incorporation) in VSMC. Cell death quantification (determined by LDH release in the culture medium) revealed that Gentisin was not cytotoxic in the investigated concentration range.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayCell Cycle/DNA Damage
-
TargetDNA/RNA Synthesis
-
RecptorDNA/RNA Synthesis
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number437-50-3
-
Formula Weight258.229
-
Molecular FormulaC14H10O5
-
Purity>98% (HPLC)
-
Solubility——
-
SMILESCOc1cc(O)c2c(c1)oc1ccc(O)cc1c2=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
molnova catalog
related products
-
Capecitabine
Prodrug of 5-Fluorouracil (5-FU). Selectively activated in tumor cells by thymidine phosphorylase; inhibits DNA synthesis upon conversion to 5-FU. Orally available.
-
PNR-7-02
PNR-7-02 is a specific inhibitor of human DNA Polymerase η (hPol η) with IC50 of 8 uM.
-
Deoxyshikonin
Deoxyshikonin may be a new drug candidate for wound healing and treatment of lymphatic diseases.
Cart
sales@molnova.com